Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury.

@article{Durst2007CannabidiolAN,
  title={Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury.},
  author={Ronen Durst and Haim Danenberg and Ruth Gallily and Raphael Mechoulam and Keren Meir and Etty Grad and Ronen Beeri and Thea Pugatsch and Elizabet Tarsish and Chaim Lotan},
  journal={American journal of physiology. Heart and circulatory physiology},
  year={2007},
  volume={293 6},
  pages={
          H3602-7
        }
}
  • R. DurstH. Danenberg C. Lotan
  • Published 1 December 2007
  • Biology, Medicine
  • American journal of physiology. Heart and circulatory physiology
Cannabidiol (CBD) is a major, nonpsychoactive Cannabis constituent with anti-inflammatory activity mediated by enhancing adenosine signaling. Inasmuch as adenosine receptors are promising pharmaceutical targets for ischemic heart diseases, we tested the effect of CBD on ischemic rat hearts. For the in vivo studies, the left anterior descending coronary artery was transiently ligated for 30 min, and the rats were treated for 7 days with CBD (5 mg/kg ip) or vehicle. Cardiac function was studied… 

Figures and Tables from this paper

Neuroprotective Effects of the Nonpsychoactive Cannabinoid Cannabidiol in Hypoxic-Ischemic Newborn Piglets

Administration of CBD after HI reduced short-term brain damage and was associated with extracerebral benefits; moreover, CBD administration wasassociated with cardiac, hemodynamic, and ventilatory beneficial effects.

The Effect of Cannabidiol on Ischemia/Reperfusion-Induced Ventricular Arrhythmias

Cannabidiol treatment significantly decreased the incidence and the duration of ventricular tachycardia, total length of arrhythmias, and the arrhythmia scores compared to control during the reperfusion period and the antiarrhythmic effect of CBD may be mediated through the activation of adenosine A1 receptor.

Therapeutic potential of cannabidiol against ischemia/reperfusion liver injury in rats.

Cannabidiol Attenuates Methamphetamine-Induced Cardiac Inflammatory Response and Necrosis through The PKA/CREB Signaling Pathway

Results indicate that chronic MA administration leads to cardiotoxicity, including cardiac inflammatory response, fibrosis, and myocardial necrosis, but these effects can be attenuated by CBD pretreatment.

Pharmacologic effects of cannabidiol on acute reperfused myocardial infarction in rabbits: evaluated with 3.0T cardiac magnetic resonance imaging and histopathology

Cannabidiol therapy reduced AMI size and facilitated restoration of LV function in rabbits induced with reperfusion injury with an experimental imaging platform, demonstrating that this experimental platform has potential theragnostic utility.

Therapeutic Applications of Cannabinoids in Cardiomyopathy and Heart Failure

CBD therapy can greatly limit the production of oxygen/nitrogen reactive species, thereby limiting cellular damage, protecting mitochondria, avoiding caspase activation, and regulating ionic homeostasis and can affect myocardial contraction.

Pharmacologic Effects of Cannabidiol on Acute Reperfused Myocardial Infarction in Rabbits: Evaluated With 3.0T Cardiac Magnetic Resonance Imaging and Histopathology

CBD therapy reduced AMI size and facilitated restoration of left ventricular function in rabbits with an experimental imaging platform, demonstrating that this experimental platform has potential theragnostic utility.
...

References

SHOWING 1-10 OF 46 REFERENCES

The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis.

Data show that CBD, through its combined immunosuppressive and anti-inflammatory actions, has a potent anti-arthritic effect in CIA.

Infarct-Sparing Effect of A2A-Adenosine Receptor Activation Is Due Primarily to Its Action on Lymphocytes

The results indicate that A2AAR activation on bone marrow–derived cells, specifically T or B lymphocytes, is responsible for the infarct-sparing and antiinflammatory effects of ATL146e administered at the time of reperfusion after coronary occlusion.

Cardioprotection With Adenosine A2 Receptor Activation at Reperfusion

Pre-ischemic treatment is seldom possible in the clinical setting of acute myocardial infarction. Thus, to successfully save myocardium from infarction, it is required that protective interventions

Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors.

Myocardial Infarct–Sparing Effect of Adenosine A2A Receptor Activation Is due to Its Action on CD4+ T Lymphocytes

It is shown that CD4+ but not CD8+ T lymphocytes contribute to myocardial ischemia/reperfusion injury and is strongly suggested that the infarct-sparing effect of A2AR activation is primarily due to inhibition of CD4-cell accumulation and activation in the reperfused heart.

Activation of Type II Cannabinoid Receptors Improves Myocardial Tolerance to Arrhythmogenic Effects of Coronary Occlusion and Reperfusion

Findings suggest that antiarrhythmic effect of HU-210 is mediated through activation of type II cannabinoid receptors rather than activation of K+-channels.

Targeting C-reactive protein for the treatment of cardiovascular disease

Therapeutic inhibition of CRP is a promising new approach to cardioprotection in acute myocardial infarction and may also provide neuroprotection in stroke and potential wider applications include other inflammatory, infective and tissue-damaging conditions characterized by increased CRP production.